Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS: CPHRF · Delayed Price · USD
6.46
-0.01 (-0.19%)
May 16, 2024, 3:42 PM EDT - Market closed
Cipher Pharmaceuticals Revenue
Cipher Pharmaceuticals had revenue of $22.25M in the twelve months ending March 31, 2024, with 10.46% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.84M with 19.54% year-over-year growth. In the year 2023, Cipher Pharmaceuticals had annual revenue of $21.55M with 4.23% growth.
Revenue (ttm)
$22.25M
Revenue Growth
+10.46%
P/S Ratio
6.97
Revenue / Employee
$3,708,796
Employees
6
Market Cap
155.06M
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21.55M | 875.09K | 4.23% |
Dec 31, 2022 | 20.68M | -1.27M | -5.78% |
Dec 31, 2021 | 21.94M | 336.00K | 1.56% |
Dec 31, 2020 | 21.61M | -844.00K | -3.76% |
Dec 31, 2019 | 22.45M | -298.00K | -1.31% |
Dec 31, 2018 | 22.75M | -17.57M | -43.58% |
Dec 31, 2017 | 40.32M | -420.00K | -1.03% |
Dec 31, 2016 | 40.74M | 6.33M | 18.40% |
Dec 31, 2015 | 34.41M | 26.15M | 316.62% |
Dec 31, 2014 | 8.26M | -17.11M | -67.44% |
Dec 31, 2013 | 25.37M | 16.87M | 198.38% |
Dec 31, 2012 | 8.50M | 5.01M | 143.22% |
Dec 31, 2011 | 3.50M | -1.89M | -35.08% |
Dec 31, 2010 | 5.38M | 2.35M | 77.34% |
Dec 31, 2009 | 3.04M | 1.77M | 139.46% |
Dec 31, 2008 | 1.27M | 724.60K | 133.38% |
Dec 31, 2007 | 543.27K | -235.73K | -30.26% |
Dec 31, 2006 | 779.00K | 132.36K | 20.47% |
Dec 31, 2005 | 646.63K | -24.77M | -97.46% |
Dec 31, 2004 | 25.42M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
CPHRF News
- 6 weeks ago - Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference - Newsfile Corp